Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in inoperable hepatocellular carcinoma
NCT00003424Phase 3Completed
- Sponsor
- National Medical Research Council
- Start
- Apr 1997
- Primary completion
- Jun 2000
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of tamoxifen in hepatocellular carcinoma (HCC), sponsored by National Medical Research Council. Started Apr 1997; status: completed.
02
Drugs
tamoxifen
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00003424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003424.